Meskill, Gerard J.
Davis, Craig W.
Zarycranski, Donna
Doliba, Markiyan
Schwartz, Jean-Charles
Dayno, Jeffrey M.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials
https://doi.org/10.1007/s40263-021-00886-x
Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials
https://doi.org/10.1007/s40263-021-00866-1
Documents that mention this clinical trial
Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials
https://doi.org/10.1007/s40263-021-00886-x
Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials
https://doi.org/10.1007/s40263-021-00866-1
Funding for this research was provided by:
Bioprojet Pharma (Study funding)
Harmony Biosciences, LLC (Funding for analysis; technical editorial and medical writing assistance)
Article History
Accepted: 28 November 2021
First Online: 21 December 2021
Declarations
:
: These studies (NCT01067222, NCT01800045) were funded by Bioprojet Pharma, Paris, France. Funding for this analysis was provided by Harmony Biosciences, LLC, Plymouth Meeting, PA, USA. Harmony Biosciences, LLC also funded open access publication of this article.
: GJM reports serving on advisory boards and on the speakers’ bureau for Harmony Biosciences and Jazz Pharmaceuticals. CWD, DZ, MD, and JMD are employees of Harmony Biosciences. JCS is a co-founder of Bioprojet Pharma.
: The datasets generated and/or analyzed for the current study are not publicly available.
: Not applicable.
: GJM: data analysis and interpretation, and review and editing of the article; CWD: conceptualization, data analysis and interpretation, and review and editing of the article; DZ: conceptualization, data analysis and interpretation, and review and editing of the article; MD: data analysis and interpretation, and review and editing of the article; JCS: data analysis and interpretation, and review and editing of the article; and JMD: data analysis and interpretation, and review and editing of the article. All authors provided input into the drafting of the manuscript, reviewed and approved the final version, and agree to be accountable for the work presented in the article.
: Both studies (NCT01067222, NCT01800045) were conducted in accordance with the Good Clinical Practice guidelines of the International Council for Harmonisation and the ethical principles of the Declaration of Helsinki. Each study protocol was approved by an institutional review board or independent ethics committee at each study site.
: All patients provided written informed consent before study enrollment.
: Not applicable.